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ABSTRACT
INTRODUCTION: Retinopathy of Prematurity (ROP) is in the focus of public health interest as far as it 
is one of the most common potentially avoidable causes of visual loss in childhood and can lead to vision im-
pairment and blindness. Therefore, it has lifelong implications for the affected children, their families, but 
also for the whole society. In Bulgaria, the processes of continuous health care transformations have led to 
lower quality control over ROP-screening processes. 
AIM OF THE STUDY: The aim of the presented study is to make a horizon scanning research, which in-
cludes: 1) introduction of some ROP-related definitions; 2) a clinical and public health overview of ROP 
from an international and Bulgarian perspective; 3) presentation of the organizational structure of screen-
ing, the early diagnosis and therapy of ROP in Bulgaria followed by public health recommendations. 
MATERIAL AND METHODS: The methods used are: a literature review of global and national data on 
ROP; postal survey - questionnaire distributed amongst the ophthalmologists who diagnose and treat ROP 
and participatory research method e.g. a follow-up of the patients’ path, the clinical and the public health 
procedures. 
RESULTS AND DISCUSSION: Globally, the three waves of the ROP-epidemic are described. National-
ly, the Bulgarian ROP-related picture is drawn, summarizing and analyzing the results from the interviews 
with ophthalmologists engaged in ROP-screening from all 28 administrative regions of Bulgaria (Period: 
April-September, 2015). Finally, after an extensive drill-down of the Bulgarian context and the global de-
velopments, locally relevant health policy strategies are proposed, like a development of a National Con-
sensus on ROP and Registry database of ROP in Bulgaria. Further, a three-level ROP-screening procedure is 
outlined and the telemedicine application is grounded.  
Keywords: retinopathy of prematurity, epidemiology, Bulgaria
INTRODUCTION 
ROP is characterized with abnormal blood ves-
sels, which are fragile and can leak (leakage syn-
drome). Those vessels can also proliferate togeth-
er with connective tissue (proliferation syndrome). 
ROP is classified in five stages, ranging from mild 
(stage I) to severe (stage V). Most babies who devel-
op ROP have stages I or II. However, in a small num-
ber of babies, ROP takes a turn for the worse, some-
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times very rapidly. Another pathological process is 
scarring of the retina and subsequent retinal detach-
ment. Retinal detachment is the main cause of visual 
impairment and total blindness in ROP (1). The cli-
nicians dealing with ROP are in a challenging situ-
ation. The effects of what is or is not done now be-
come apparent only months to years later (2). Un-
treated ROP threatens to destroy vision. The smaller 
a baby is at birth, the more likely that baby is to devel-
op ROP. Therefore, the standards and definitions, re-
lated to prematurity need to be clear. Today, with the 
advances in neonatal care, smaller and more prema-
ture infants are being saved. Obviously, these infants 
are at a much higher risk for ROP.
Globally, ROP is in the focus of public health in-
terest as far as it is one of the most common poten-
tially avoidable causes of visual loss in childhood and 
can lead to lifelong vision impairment and blind-
ness. ROP has lifelong implications for the affected 
children, their families, but also for the whole soci-
ety. In Bulgaria, the processes of continuous health 
care transformations lead to lower control over ROP- 
screening processes. Therefore, our aim is to make a 
horizon scanning research, which includes: 1) intro-
duction of some ROP-related definitions; 2) a clini-
cal and public health overview of ROP from an inter-
national and Bulgarian perspective; 3) presentation 
of the organizational structure of the early diagnosis 
and treatment of ROP in Bulgaria, followed by public 
health recommendations. 
MATERIALS AND METHODS
The research strategy was based on a literature 
review of global and national data on ROP in order 
to investigate this preventable visual loss as a public 
health issue. Further, to identify the national public 
health challenges-related to ROP, a postal survey was 
carried out amongst the specialists who are engaged 
in monitoring, diagnostics and treatment of ROP in 
the 28 administrative regions in Bulgaria (within the 
period of April-September, 2015). A participatory re-
search method e.g. a follow-up of the patients’ path 
and the clinical and public health procedures relat-
ed to ROP has been applied. This was possible only 
through the close collaboration with the Regional 
Health Inspectorate of Stara Zagora. The question-
naire was designed especially for the survey and in-
cluded five questions requiring information on ROP-
related activities - screening, diagnostics and treat-
ment. Hereafter, the information received from the 
questionnaire is summarized and analyzed.
On the bases of the research and the following 
discussion about the reasons for the “third epidem-
ic” (3) of ROP, locally relevant health policy strate-
gies are proposed for management of the ROP con-
trol, which ensure that all babies at risk are examined 
in order to avoid any preventable visual loss. The idea 
is to build a bridge between public health and clinical 
practice, supporting it with facts and evidence-based 
recommendations and national public health guide-
lines, which should support the processes of screen-
ing, diagnosing and treating ROP.  
Definitions Related to ROP
There is no unified definition of a preterm baby. 
Nearly every country has its own standards. There-
fore, the WHO-definition of preterm birth is pre-
sented: “...babies born alive before 37 weeks of preg-
nancy are completed…” Sub-categories of preterm 
birth, based on weeks of gestational age are defined 
as follow: Extremely preterm (<28 weeks); Very pre-
term (28 to <32 weeks); Moderate to late preterm 
(32 to <37 weeks). Note: Births at 37 to 39 weeks still 
have suboptimal outcomes, and induction or cesare-
an birth should not be planned before 39 completed 
weeks unless medically indicated (4). The USA stan-
dards (5) of premature infant/preterm neonates are: 
weighing about 1250 grams (2¾ pounds) or less and 
born before 31 weeks of gestation (A full-term preg-
nancy has a gestation period of 38–42 weeks). In Bul-
garia, the medical standards were changed in 2014 
and a premature baby is defined as such based on the 
weight at birth - up to 2499 grams and/or the dura-
tion of pregnancy up to 37 weeks of gestation (6).
 The ROP-screening has a direct contribution 
to the health of the individual e.g. the preterm ne-
onates and at its initial level is a kind of ‘case-find-
ing’ process. Herewith the ROP-screening methods 
are defined: 
Direct ophthalmoscopy is a method of exam-
ination of the fundus directly using a handheld in-
strument which provides erect, virtual image of the 
retina. The field of view is only 50, and stereoscopic 
vision for the examiner is not possible (7).  
Binocular indirect ophthalmoscopy (BIO) 
produces an inverted and reversed real image on the 
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proximal side of a handheld condensing lens, onto 
which the examiner accommodates. It is a widely 
used method for posterior segment examination be-
cause of its large field, depth of focus, stereopsis, good 
illumination, and ease of use with scleral indentor (a 
device used to facilitate examination of the retinal 
periphery) (7). The conventional method, which is 
also accepted as the gold standard, for ROP screening 
is BIO with scleral indentation. ROP screening with 
this technique is difficult, particularly in developing 
countries, because it requires a specialized pediatric 
ophthalmologist experienced in ROP screening (8).  
The RetCam (Clarity Medical Systems), a reti-
nal wide-field digital imaging system (WFDI), allows 
documentation of large parts of the retina of the alert 
infant within minutes. The advantage of this meth-
od is that it can be performed by a trained nurse or 
midwife (9-12). 
By definition, Telemedicine is “the use of elec-
tronic information and communications technol-
ogies to provide and support health care when dis-
tance separates the participants (13).  Telemedicine 
combined with WFDI offers the opportunity for 
improved ROP screening by expert evaluation of the 
images independent of the screening site (14).  
ROP – Epidemiology and Screening
ROP is a public health challenge as far as it af-
fects long-term physical health with a higher risk of 
blindness, high myopia or strabismus. These effects 
exert a heavy burden on families, society and the 
health system (15). Around 25% of all extremely pre-
term babies are affected by ROP. There is a risk also 
in moderately preterm babies especially if the oxygen 
therapy is overdosed and poorly monitored.
Global Information- The Three Waves of the 
ROP-Epidemic
Every year, about 15 million babies are born 
prematurely - more than one in 10 of all babies born 
around the world (4). The worldwide prevalence of 
blindness due to ROP is approximately 50,000. Most 
studies report ROP incidence about 60% for babies 
less than 1500 g (16). In the industrialized world, 
ROP is the cause for 15% of the blindness, while in 
middle- and low-income countries it causes 60% of 
the blindness (17). 
ROP was a major cause of blindness in the USA 
and Western Europe 50-60 years ago. This occurred 
because all preterm infants were given 100% oxygen 
whether they needed it or not. Oxygen has a specific 
“toxicity” to the blood vessels, including those in the 
retina. After the role of oxygen was understood, and 
it was used less freely, blindness from ROP declined 
dramatically. Until very recently ROP was, there-
fore, seen as a condition of the West, and an iatro-
genic problem that had been solved. Nowadays, ROP 
has become a public health issue in the developing 
world also.
In the Western world there have been two, iden-
tified in the academic literature, notable epidemics 
over the past 60 years. Severe ROP (initially termed 
“retrolental fibroplasia”) was first diagnosed in 1942 
during an epidemic of the disease in the 1940s (18). 
It was suggested in 1951 that the toxic effects of un-
controlled supplemental oxygen to newborns were 
the reason for the epidemic (19). As a result of con-
trolled oxygen administration this epidemic ceased. 
For example, in the United States alone, the propor-
tion of blindness due to ROP fell from 50% in 1950 to 
4% by 1965 (20).  Unfortunately, this decline was ac-
companied by an increase in neonatal deaths from 
atelectasis and respiratory distress secondary to hya-
line membrane disease (21). The late 1970s and 1980s 
were the period of the second ROP-epidemic (22,23), 
which was similar in size to the first despite the care-
ful monitoring of oxygen delivery to neonates since 
the 1950s. This second wave of ROP-epidemic was 
due to increased survival rates of very low birth-
weight premature infants weighing 750-999g and not 
to new iatrogenic factors (24). Survival rates for pre-
mature infants less than 27 weeks gestation contin-
ued to improve in the 1990s and, while some studies 
showed greater occurrence of more severe ROP, 24 
more recent reports indicate a decline in incidence, 
severity, and progression in the developed countries. 
ROP remains prevalent in very low birthweight in-
fants, with as many as 12.5% of infants born between 
23 and 26 weeks gestation requiring treatment (25).
Over the last 10-15 years it has become clear 
that the incidence and prevalence of ROP is rising 
again and is a major cause of blindness in children in 
middle-income countries in Latin America, Eastern 
Europe and the emerging economies of South-East-
ern Asia. It has been increasingly reported in Chi-
na and India. The third wave of ROP-epidemics has 
been identified (3). This is happening because the ex-
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panding neonatal care in these countries is without 
adequate experience with screening and managing 
ROP. Rates of ROP requiring treatment also tend to 
be higher in middle- and low-income countries sug-
gesting that babies are being exposed to risk factors 
which are, to a large extent, controlled in industrial-
ized countries. 
The screening for ROP in the United States is 
organized in the following way: the premature ne-
onates are examined for ROP if they have a birth 
weight of less than or equal to 1500g or a gestational 
age of 30 weeks or less. Selected infants with a birth 
weight between 1500g and 2000g or a gestation-
al age at birth of greater than 30 weeks with an un-
stable clinical course should also have an eye exam 
(26). The UK ROP screening guidelines are as fol-
lows: “All babies less than 31 weeks gestational age 
(up to 30 weeks and 6 days) or less than 1251g birth-
weight must be screened for ROP. One criterion need 
to be fulfilled to meet the criteria for inclusion in the 
screening“ (27). Extensive meta-analysis of world-
wide guidelines suggests that if all infants with a ges-
tational age of 30 weeks and 6 or 7 days or less (re-
gardless of birth weight), as well as any infant with a 
birth weight of 1250g or less are screened, the likeli-
hood of an unscreened infant developing advanced 
stage ROP, for which treatment should be offered, is 
extremely low (25).
Regional Information - Bulgaria – Situations 
and Challenges
Globally, in the last three decades, epidemiolog-
ic studies have made fundamental contributions to 
the understanding of the etiology and management 
of blindness and low vision, respectively of ROP (28). 
Nowadays, ROP is a leading cause of preventable 
childhood blindness in middle-income countries (1). 
In the former Soviet Bloc countries, the incidence of 
severe ROP varies between prosperous and middle-
income countries (16). Nationally, there are only re-
gional studies, which provide data on ROP epidemi-
ology in Bulgaria (29,30). However, lack of systematic 
data on preterm birth and related ROP at a country 
level has hampered public health policy in Bulgaria. 
There are 67 585 infants born in Bulgaria in 
2014; of those, 6349 are premature. The medical 
standards of prematurity have been changed over the 
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the former periods of time would be irrelevant (31). 
There is no official data on incidence and prevalence 
of ROP among those infants. In order to get a more 
clear picture of health care infrastructure and proce-
dures, related to ROP, a survey was carried out and a 
questionnaire was distributed amongst the ophthal-
mologists from all 28 administrative regions of Bul-
garia who are performing ROP screening (Period: 
April-September, 2015).
The results from the survey indicate that cur-
rently the ROP-screening in Bulgaria is performed 
by an ophthalmologist in the obstetric units (lev-
el II or III of competence) or neonatal intensive care 
units (level III) but eye specialists are not appointed 
to this units. There are several eye units in Bulgar-
ia, using retinal cameras for screening of ROP. The 
ROP-screening is performed in 21 administrative 
units (camera or ophthalmoscopy), while ROP-eval-
uation for severe or moderate ROP is carried out in 
only 18 administrative regions. The therapy of pre-
term babies, related to ROP is carried out in four re-
gions – Burgas, Varna, Plovdiv and Sofia. In seven re-
gions - Blagoevgrad, Vidin, Dobrich, Kjustendil, Per-
nik, Razgrad and Jambol there are no activities relat-
ed to ROP-screening and diagnostics. The main rea-
son for that is lack of health care structure and spe-
cialists with such competences (see Table 1.).
Types of screening tests used in practice:
Indirect ophthalmoscopy as a screening meth-
od performed in 9 regions. Direct ophthalmoscopy 
is more widely used – in 18 regions. The reasons for 
that are two: most of the neonatology units have only 
rudimentary equipment and secondly, some eye doc-
tors are not used to indirect ophthalmoscopy. The 
two methods for screening of ROP are applied in six 
regions. Photography of the retina for ROP-screen-
ing is reported by the ophthalmologists who work 
in 5 regions. Telescreening is currently used in one 
health care unit in Sofia (see Table 2.). 
Diagnostics of ROP is performed in health care 
units in 18 Bulgarian regions. The main diagnostic 
method is the indirect ophthalmoscopy, which is ac-
cepted as a “golden standard” and applied in 10 re-
gions. Fundus photography with retinal cameras is 
used as a main or compulsory diagnostic method in 7 
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with indirect ophthalmoscopes or retinal cameras, 
perform direct ophthalmoscopy (see Table 3). 
The therapy of the children is carried out only 
in the cities of Burgas, Varna, Plovdiv and Sofia. In 
Burgas, cryotherapy is performed, while in the other 
cities laser therapy is also applied. There is a limited 
opportunity for anti-VEGF-drug therapy in Bulgar-
ia, only in Sofia, where two units apply it as a treat-
ment of last resort. 
Analyses show that the territory of the coun-
try where 84.8% of the population live and 90.4% of 
all preterm babies are born, are covered with ROP 
screening and diagnostic activities but there is no 
universal accessibility and availability of good qual-
ity ROP-health care services. Moreover, the ongoing 
transformations in our health care system have bro-
ken the old centralized system of screening while the 
new one is still fragile, needs public health support 
and harmonization with the global developments.  
ROP- Discussion and Recommended Strategies
The World Health Organization’s Vision 2020 
program targets ROP as an “avoidable disease” re-
quiring early detection and treatment to prevent 
blindness and the inherent costs to the individu-
al and the community (4,17). As described by Vi-
sion 2020, recent research has resulted in strategies 
that have been successful in reducing the incidence 
of ROP such as routine fundus examination of pre-
mature neonates less than 32 weeks’ gestation or un-
der 1250g, provision of carefully monitored levels of 
supplemental oxygen, where necessary, and treat-
ment and care by well-trained and well-equipped 
ophthalmologists. As a lower-cost option for devel-
oping countries, screening only infants under 1200g 
may be more cost-effective (32). Current treatment 
options are expensive and can have potentially se-
rious complications (33); thus, prevention is still the 
best strategy available at present to avoid blindness 
caused by ROP (25). In Bulgaria, CRYO and LASER 
therapy are available in 6 centers, and anti-VEGF 
therapy is associated with some legal problems. In 
many countries anti-VEGF is the treatment of choice 
with extremely good results and much less risks in 
comparison to coagulation.
Public Health Recommendations: 
ROP is a pathological process the progress of 
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creates a requirement for at-risk preterm infants to 
be examined at proper times and intervals to detect 
the changes of ROP before they become permanently 
destructive. These recommendations present the at-
tributes on which an effective program for detecting 
and treating ROP could be based, including the tim-
ing of the initial examination and subsequent reex-
amination intervals. According to the International 
Agency for the Prevention of Blindness (IAPB), pub-
lic health control and regulations entail improving 
neonatal care, the delivery of oxygen in particular, 
and detecting infants who develop the treatable stag-
es of disease, followed by laser to the peripheral reti-
na. These aspects of control are effective at reducing 
blindness from ROP (34).  
Herewith, are presented our public health rec-
ommendations concerning ROP-related procedures 
in Bulgaria. They are formulated after an extensive 
drill-down of the Bulgarian context and the glob-
al developments and will be framed in three main 
groups as follows:
1. Need for a National Consensus and Registry 
Database in Bulgaria. 
On a national level, there is a need for a Nation-
al Consensus on the screening and therapy of ROP. 
Regulations for the development of a National Reg-
istry Database, which can be a part of the National 
Register of Premature Children 2014/2020 could be 
included in this consensus (35). Although there is no 
standardized register system, there are several coun-
tries which manage national registers on blindness 
and visual impairments of the age below 19 years: 
Canada, UK (0-15 years of age), Finland (Finnish 
Register of Visual Impairments), Kuwait (THE Reg-
istry of Visual Impairment Committee), Australia 
(Australian Childhood Vision Impairment Regis-
ter – 0-18 years of age) (36). An International Work-
shop on ROP was organized in 2009 in Varna, Bul-
garia, which resulted with a draft for a National Pro-
gram on Screening and treatment of ROP and it can 
be used as bases for the above-mentioned health pol-
icy instruments. 
2. Three-Levels Screening Procedure Proposal.
Effective services for ROP-screening and treat-
ment must be embedded in a robust organizational 
structure, with the individual responsibilities iden-
tified. Particular effort must be made to ensure that 
the service is delivered appropriately for all those at 
risk, as there is evidence that babies transferred or 
discharged home before screening is complete are at 
risk of poor outcome as a result of a lack of follow-up. 
A three-level screening procedure is proposed, which 
is cost-effective and most of the procedures could be 
performed by the non-physician staff. 
 ❖ Primary Level - at the neonatology department 
- screening by a trained physician (neo-natal 
specialist) on the bases of which it is decided 
which one of the preterm newborns will be ex-
amined on RetCam
 ❖ Secondary Level - RetCam – this should also 
be performed at the neonatal department, and 
could be done by trained staff. 
 ❖ Tertiary Level - A specialist overview of the 
RetCam images and decision for clinical exam-
ination, when risk is identified.
In the proposed above three-level screening 
procedure the role of telemedicine could be pivotal, 
if it is available.
3. The Telemedicine Approaches.
One of the greatest challenges in less-developed 
countries is having adequate screening done by oph-
thalmologists trained to diagnose ROP with indi-
rect ophthalmoscopy. Telemedicine, with the use of 
digital imaging and fundus photography, may also 
be a potential strategy for ROP screening in regions 
where there are few trained ophthalmologists who 
can manage ROP (26). 
The Telemedicine approaches  are innovative 
for identifying babies at greater risk of developing 
severe ROP, especially those in underserved or re-
mote mountain areas or places with a lack of spe-
cialists. Through such approach is possible to accu-
rately detect potentially severe ROP by sending ret-
inal images taken in the neonatology department to 
an offsite image reading center. Non-physician staff 
can be responsible for taking the photos, which will 
be available to trained image readers, who will eval-
uate whether the babies need to be referred for po-
tential treatment. A study in USA (5) found that this 
telemedicine approach in identifying severe ROP was 
about as accurate as regular examinations by an oph-
thalmologist. The telemedicine approach  potential-
ly gives hundreds of premature babies in Bulgaria a 
greater access to ROP screening.
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Finally, and most importantly, ROP is not a dis-
ease that occurs in vacuum; it has many implications 
for the society. The blindness and visual impairment 
that are its most feared outcomes are of enormous 
cost to its victims and to all of us as well. Now we 
know that a true epidemic is emerging because ROP 
occurs at a greater frequency than usually expected. 
Hence, ROP is “unfinished agenda” (3) for ophthal-
mic and pediatric communities as well as for pub-
lic health professionals who are responsible for the 
evidence-based epidemiological research and health 
policy development. The conclusion is that while sig-
nificant reductions in the disease rates have occurred 
in developed countries, further research is required 
to fully understand and prevent the disease in Bul-
garia. In the meantime, development and implemen-
tation of appropriate screening and treatment strat-
egies will be critical in reducing blindness in our 
country. 
To sum up, the reasons for this “third epidem-
ic” of ROP have been discussed together with strat-
egies for control, including the need for evidence-
based criteria which ensure that all babies in Bulgar-
ia born at risk are examined. Consequently, from a 
public health perspective, ROP is targeted as an im-
portant but avoidable disease. 
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